AGT and cardiomyopathy: Yamazaki et al. found that PFD treatment results in a significant reduction of left ventricular hypertrophy and cardiac fibrosis in an Ang II-induced mouse hypertrophic model14, suggesting that the RAS may be a novel target of PFD for treatment of cardiomyopathy.